Gunderson Dettmer represented client Rarebreed Veterinary Partners, a technology-enabled veterinary services platform, in its Series C financing and minority investment by Trilantic North America.

In the announcement of the transaction co-founder and CEO of Rarebreed Dan Espinal said, “Trilantic North America has a long track record of partnering with founder-led businesses, and quickly understood our focus on service delivery and our objective to attract leading veterinary talent to the Rarebreed platform. This investment enhances our ability to further invest and deliver a truly exceptional work experience for animal healthcare professionals.”

The Gunderson deal team was led by Jeff Engerman and included Erik Thompson and Frances Sevilla-Sacasa.